Clinical Trial 50936

Overland Park, KS 66210


Phase III Randomized, double blind, placebo controlled trial of adjunctive Troriluzole in Obsessive Compulsive Disorder. 

Troriluzole is a glutamate modulating drug that is being developed for potential treatment of OCD as adjunctive therapy to standard of care treatments in subjects who have experienced an inadequate response to current pharmacotherapy.


Male and Female ages 18-65

Diagnosis of OCD greater than 1 year

Subjects must be currently experiencing non-response or inadequate response to their current standard of care medication.

Must currently be on an SSRI for at least 8 weeks.

Qualified Participants May Receive:

$75 per each completed visit

Available At:

Collective Medical Research
7501 College Blvd
suite 100
Overland Park, KS 66210
View Clinic Location


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.